Charles J. Vecht

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations

Medicine, Oncology, Radiation Oncology +17

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery

Charles J. Vecht, Hanny Haaxma‐Reiche, Evert M. Noordijk et al. · Annals of Neurology · 1993 · 1.1K citations

Medicine, Neurosurgery, Oncology +11

Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma

Francesco Pignatti, Martin J. van den Bent, Desmond Curran et al. · Journal of Clinical Oncology · 2002 · 948 citations

Medicine, Oncology, Surgery +17

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin J. van den Bent, Alba A. Brandes, Marc Sanson et al. · Journal of Clinical Oncology · 2006 · 744 citations

Medicine, Oncology, Radiation Oncology +17